Q1 2014 13F Holders as of 31 Mar 2014
-
Type / Class
-
Equity / Common Stock par value $0.012 per share
-
Shares outstanding
-
41M
-
Number of holders
-
21
-
Total 13F shares, excl. options
-
1.31M
-
Shares change
-
+433K
-
Total reported value, excl. options
-
$15.3M
-
Value change
-
+$5.08M
-
Number of buys
-
14
-
Number of sells
-
-6
-
Price
-
$11.78
Significant Holders of ORAMED PHARMACEUTICALS INC. - Common Stock par value $0.012 per share (ORMP) as of Q1 2014
26 filings reported holding ORMP - ORAMED PHARMACEUTICALS INC. - Common Stock par value $0.012 per share as of Q1 2014.
ORAMED PHARMACEUTICALS INC. - Common Stock par value $0.012 per share (ORMP) has 21 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 1.31M shares
of 41M outstanding shares and own 3.2% of the company stock.
Largest 10 shareholders include MARXE AUSTIN W & GREENHOUSE DAVID M (790K shares), STIFEL FINANCIAL CORP (251K shares), GREYLIN INVESTMENT MANGEMENT INC (84.9K shares), COLUMBUS CIRCLE INVESTORS (44.7K shares), MORGAN STANLEY (26.3K shares), SUSQUEHANNA INTERNATIONAL GROUP, LLP (24.3K shares), HSBC HOLDINGS PLC (15K shares), TOCQUEVILLE ASSET MANAGEMENT L.P. (15K shares), JANE STREET GROUP, LLC (14.9K shares), and CREDIT SUISSE AG/ (12K shares).
This table shows the top 21 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.